Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Reliability of GFR Estimated by Creatinine-Based Formulas in Moderate-to-Severe Proteinuria
Carmine Zoccali, Pasquale Fabio Provenzano, Giovanni Tripepi, Fabiola Carrara, Francesca Mallamaci, Annalisa Perna, Pierre Delanaye, Piero Ruggenenti, Giuseppe Remuzzi (2024). Reliability of GFR Estimated by Creatinine-Based Formulas in Moderate-to-Severe Proteinuria. , 20(2), DOI: https://doi.org/10.2215/cjn.0000000602.
Article43 days agoAnti–Phospholipase A2 Receptor 1 and Anti–Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study
Piero Ruggenenti, Linda Reinhard, Barbara Ruggiero, Annalisa Perna, Luca Perico, Tobia Peracchi, Diego Fidone, Alessia Gennarini, Ariela Benigni, Monica Cortinovis, Elion Hoxha, Giuseppe Remuzzi (2023). Anti–Phospholipase A2 Receptor 1 and Anti–Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study. , 83(5), DOI: https://doi.org/10.1053/j.ajkd.2023.10.013.
Article43 days agoA phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome
Marina Vivarelli, Manuela Colucci, Mattia Algeri, Federica Zotta, Francesco Emma, Ines L’Erario, Marco Busutti, Stefano Rota, Chiara Capelli, Martino Introna, Marta Todeschini, Federica Casiraghi, Annalisa Perna, Tobia Peracchi, Andrea De Salvo, Nadia Rubis, Franco Locatelli, Giuseppe Remuzzi, Piero Ruggenenti (2023). A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome. , 8(18), DOI: https://doi.org/10.1172/jci.insight.169424.
Article43 days agoEffects of Octreotide–Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial
Matias Trillini, Anna Caroli, Norberto Perico, Andrea Remuzzi, Paolo Brambilla, Giulia Villa, Annalisa Perna, Tobia Peracchi, Nadia Rubis, Davide Martinetti, Rosa Caruso, Valentina Fanny Leone, Daniela Cugini, Fabiola Carrara, Giuseppe Remuzzi, Piero Ruggenenti (2023). Effects of Octreotide–Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial. , 18(2), DOI: https://doi.org/10.2215/cjn.0000000000000049.
Article43 days agoOfatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series
Manuel Alfredo Podestà, Matias Trillini, Valentina Portalupi, Alessia Gennarini, Federica Tomatis, Alessandro Villa, Annalisa Perna, Nadia Rubis, Giuseppe Remuzzi, Piero Ruggenenti (2023). Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series. , 83(3), DOI: https://doi.org/10.1053/j.ajkd.2023.08.010.
Article43 days ago